Anna Schell
Family · Washington, MONPI 1518341734
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $900, more than ten times the $25 reported in 2023.
Across 84 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$186
- AstraZeneca$150
- AbbVie$141
- Radius Health, Inc.$140
- Novo Nordisk$132
- Pfizer$114
- plus $730 from 18 others
What the payments were for
- Food & beverage$1,592100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 9 | $186 |
| AstraZeneca | 9 | $150 |
| AbbVie | 6 | $141 |
| Radius Health, Inc. | 6 | $140 |
| Novo Nordisk | 8 | $132 |
| Pfizer | 7 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Lilly USA, LLC | 5 | $78 |
| Amgen | 4 | $75 |
| Bayer | 4 | $73 |
| Esperion Therapeutics, Inc. | 3 | $59 |
| GSK | 3 | $50 |
| Astellas Pharma US Inc | 2 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Lundbeck LLC | 1 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Itamar Medical Inc | 1 | $25 |
| Organon | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Medtronic | 1 | $21 |
| Edwards Lifesciences | 1 | $19 |
| Tris Pharma Inc | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,592 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 32 | $39,706 |
| JardianceEmpagliflozin | 32 | $33,966 |
| TrulicityDulaglutide | 19 | $26,956 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $21,319 |
| EliquisApixaban | 19 | $21,244 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 17 | $9,620 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $9,054 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $3,454 |
| Bupropion XlBupropion Hcl | 45 | $2,316 |
| Mirtazapine | 31 | $1,801 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 56 | $1,451 |
| Levothyroxine Sodium | 103 | $1,234 |
| Losartan Potassium | 68 | $937 |
| Rosuvastatin Calcium | 75 | $877 |
| Atorvastatin Calcium | 97 | $765 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $132 | $39,70632 claims |
| Boehringer IngelheimJardiance | $14 | $33,96632 claims |
| Lilly USA, LLCTrulicity | $78 | $26,95619 claims |
| GSKTrelegy Ellipta | $50 | $21,31933 claims |
| PfizerEliquis | $114 | $21,24419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.
Other family in Washington
- Dana HellebuschWashington$24K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.